References
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics – 2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.10.1161/CIR.0000000000000558
- Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611–619.10.1001/jama.297.6.611
- Arbab-Zadeh A, Nakano M, Virmani R, et al. Acute coronary events. Circulation. 2012;125(9):1147–1156.10.1161/CIRCULATIONAHA.111.047431
- Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92(3):657–671.10.1161/01.CIR.92.3.657
- Martin SS, Blaha MJ, Blankstein R, et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation. 2014;129(1):77–86.10.1161/CIRCULATIONAHA.113.003625
- Baber U, Mehran R, Sartori S, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol. 2015;65(11):1065–1074.10.1016/j.jacc.2015.01.017
- Nicolaides A, Panayiotou AG. Screening for atherosclerotic cardiovascular risk using ultrasound. J Am Coll Cardiol. 2016;67(11):1275–1277.10.1016/j.jacc.2016.01.016
- Hansson GK. Inflammation and atherosclerosis: the end of a controversy. Circulation. 2017;136(20):1875–1877.10.1161/CIRCULATIONAHA.117.030484
- Bale B, Doneen A, Cool LC. Beat the heart attack gene: the revolutionary plan to prevent heart disease stroke and diabetes. New York (NY): Wiley; 2014.
- Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.10.1161/CIRCULATIONAHA.109.192703
- Pessi T, Karhunen V, Karjalainen PP, et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation. 2013;127(11):1219–1228; e1211–1216.10.1161/CIRCULATIONAHA.112.001254
- Bale BF, Doneen AL, Vigerust DJ. High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Postgrad Med J. 1098;2017(93):215–220.
- Kotchen TA, Cowley AW, Liang M. Ushering hypertension into a new era of precision medicine. JAMA. 2016;315(4):343–344.10.1001/jama.2015.18359
- Houser SR. The American Heart Association’s new institute for precision cardiovascular medicine. Circulation. 2016;134(24):1913–1914.10.1161/CIRCULATIONAHA.116.022138
- https://www.oraldna.com/Resources/CelsusOneSampleReport.pdf
- Feng D, Esperat MC, Doneen AL, et al. Eight-year outcomes of a program for early prevention of cardiovascular events: a growth-curve analysis. J Cardiovasc Nurs. 2015;30(4):281–291.10.1097/JCN.0000000000000141
- Cheng HG, Patel BS, Martin SS, et al. Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community-based prevention clinic. Arch Med Sci. 2016;12(4):728–735.10.5114/aoms.2016.60955
- Madder RD, Husaini M, Davis AT, et al. Large lipid-rich coronary plaques detected by near-infrared spectroscopy at non-stented sites in the target artery identify patients likely to experience future major adverse cardiovascular events. Eur Heart J Cardiovasc Imaging. 2016;17(4):393–399.10.1093/ehjci/jev340
- Sun J, Zhao XQ, Balu N, et al. Carotid plaque lipid content and fibrous cap status predict systemic CV outcomes: the MRI substudy in AIM-HIGH. JACC Cardiovasc Imaging. 2017;10(3):241–249.10.1016/j.jcmg.2016.06.017
- Xing L, Higuma T, Wang Z, et al. Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study. J Am Coll Cardiol. 2017;69(20):2502–2513.10.1016/j.jacc.2017.03.556